Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...

In a recent study published in EBioMedicine, a group of researchers determined the impact of nicotinamide mononucleotide (NMN) on Clusters of differentiation 4 + (CD4 +) Thymus cells (T cells) viz. T ...

A review found that CD4/CD8 ratio could be used as a prognostic marker for mortality in patients with HIV, though future studies need to be done to confirm these findings. Clinical practices can ...

In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...

A new CD4 testing system, the BD FACSPresto Near Patient CD4 Counter system (BD Biosciences), enables patients to monitor their HIV/AIDS, potentially reducing the probability of transmitting the ...

The circumstances surrounding a study on a deadly virus could hardly have been more dramatic. One of its first authors was forced to flee his homeland when it became a war zone. More than 2,000 ...

A new vaccine design uses folded DNA to steer the immune system toward producing the rare immune cells needed to make protective antibodies against HIV.